Documentos de Académico
Documentos de Profesional
Documentos de Cultura
BIOPOLIS es una empresa que nace como un spin-off del CSIC, el principal
organismo investigador en España
Es una empresa que usa la excelencia científica como una herramienta para
comercializar productos de alto valor añadido
– Ayuda al mantenimiento de la
función de barrera intestinal y para
favorecer la absorción de los
alimentos
FOS
FOS
FOS
FOS
Utilidad de Gasteel Kid
• Refuerzo inmunitario • Alteraciones gastrointestinales
• Izquierdo E, Medina M, Ennahar S, Marchioni E, Sanz . (2008). Resistance to simulated gastrointestinal condtions and adhesions
to mucus as probiotic criteria for Bifidobacterium longum strains. Current Microbiology 56: 613-618
• Medina M, de Palma G, Ribes-Koninckx C, Calabuig M, Sanz Y. (2008). Bifidobacterium strains suppress in vitro the pro-
inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. Journal of Inflammation 3: 5-19
• Laparra JM, Sanz Y. (2010). Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via
modifications of toxic peptide generation during digestion. Journal of Cell Biochemistry 109: 801-807
• Olivares M, Laparra M, Sanz Y. (2011). Influence of Bifidobacterium longum CECT 7347 and gliadin peptides on intestinal
epithelial cell proteome. Journal of Agricultural and Food Chemistry 59: 7666-7671
• Laparra JM, Olivares M, Gallina O, Sanz Y. (2012). Bifidobacterium longum CECT7347 modulates immune responses in a
gliadin-induced enteropathy animal model. PLoS ONE 7: e30744
• de Palma G, Kamanova J, Cinova J, Olivares M, Drasarova H, Tuckova L, Sanz Y. (2012). Modulation of phenotypic and
functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease. Journal of Leukocyte
Biology 92: 1043-1054
• Olivares M, Laparra M, Sanz Y. (2012). Oral administration of Bifidobacterium longum CECT 7347 modulates jejunal proteome
in an in vivo gliadin-induced enteropathy animal model. Journal of Proteomics 77: 310-320
• Chenoll E, Codoñer FM, Silva A. Ibañez, Martínez-Blanch JF, Bollati-Fogolin M, Sanz Y, Ramón D, Genovés S. (2013). Genomic
sequence and pre-clinical safety assessment of Bifidobacterium longum CECT7347, a probiotic able to reduce the toxicity
and inflammatory potential of gliadin-derived peptides. Journal of Probiotics and Health 1: 106 doi:10.4172/jph.1000106
• Laparra JM, Olivares M, Sanz Y. (2013). Oral administration of Bifidobacterium longum CECT 7347 ameliorates gliadin-induced
alterations in liver iron mobilization. British Journal of Nutrition 110: 1828-1836
DOSSIER CIENTÍFICO (II)
• Laparra JM, Olivares M, Sanz Y. (2013). Oral administration of Bifidobacterium longum CECT 7347 ameliorates gliadin-induced
alterations in liver iron mobilization. British Journal of Nutrition 110: 1828-1836
• Muñoz-Quesada S, Chenoll E, Vieites JM, Genovés S, Maldonado J, Bermúdez-Brito M, Gómez-Llorente C, Matencio E, Bernal
MJ, Romero F, Ramón D, Gil A. (2013). Isolation, identification and characterization of three novel probiotic strains
(Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNMC I-4035 and Lactobacillus rhamnosus CNMC I-4036) from
the faeces of exclusively breast-fed infants. British Journal of Nutrition 109: S51-S62.
• Muñoz-Quesada S, Bermudez-Brito M, Chenoll E, Genovés S, Gómez-Llorente C, Plaza-Diaz J, Matencio E, Bernal MJ, Romero
F, Ramón D, Gil A. (2013). Competitive inhibition of three novel bacteria isolated from faeces of breast milk fed infants against
selected entheropathogens. British Journal of Nutrition 109: S63-S69.
• Díaz JP, Gómez-Llorente C, Campaña-Martín L, Matencio E, Ortuño I, Martínez-Silla R, Gómez-Gallego C, Periago MJ, Ros G,
Chenoll E, Genovés S, Corella D, Portolés O, Romero F, Ramón D, Pérez A, Gil A, Fontana L. (2013). Safety and
immunomodulatory effects of three probiotic strains isolated from feces of breast-fed infants in healthy adults: SETOPROB
study. PLOS ONE 8: e78111.
• Olivares M, Castillejo G, Varea V, Sanz Y. (2014). Double-blind, randomized, placebo-controlled intervention trial to evaluate
the effects of Bifidobacterium longum CECT 7347 on children with newly diagnosed celiac disease. British Journal of Nutrition
112: 30-40.
• Bermudez-Brito M, Muñoz-Quesada S, Gómez-Llorente C, Romero F, Gil A. (2014). Lactobacillus rhamnosus and its cell-free
culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells.
British Journal of Nutrition 111: 1727-1731.
• Plaza-Diaz J, Gómez-Llorente C, Abadia-Molina F, Saez-Lara MJ, Campaña-Martin L, Muñoz-Quezada S, Romero F, Gil A,
Fontana L. (2014). Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus
rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLOS ONE 9: 98401.
• Plaza-Díaz J, Fernández-Caballero JA, Chueca N, García F, Gómez-Lorente C, Sáez-Lara MJ, Fontana L, Gil A. (2015).
Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults whoi received a daily dose of
immunomodulatory probiotic strains. Nutrients 7: 3099-4015.
Utilidad de Gasteel Plus
• Refuerzo inmunitario:
– Situaciones de estrés
• Alteraciones gastrointestinales – Tras superar cuadros gripales o
(diarrea): catarrales
– Cuadros gastrointestinales de – Periodos de cansancio y fatiga:
origen vírico cambios de estación, exceso de
trabajo,…
– Como consecuencia de
tratamiento con antibióticos
Resumen
• Gasteel está indicado en adultos (17-50 años):
– Con alteraciones gastrointestinales inespecíficas
– Diarreas postmedicamentosas o infecciosas
– Como refuerzo inmunitario